(Q33215518)

24 July 2017

0 references

Intake of vitamin E, vitamin C, and carotenoids and the risk of Parkinson's disease: a meta-analysis (English)

1 reference

24 July 2017

0 references

0 references

1 reference

1 reference

Mahyar Etminan

1

1 reference

24 July 2017

Sudeep S Gill

series ordinal

2

1 reference

24 July 2017

Ali Samii

series ordinal

3

1 reference

24 July 2017

language of work or name

1 reference

1 June 2005

1 reference

24 July 2017

1 reference

24 July 2017

4

1 reference

24 July 2017

6

1 reference

24 July 2017

362-365

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2805%2970097-1

24 July 2017

1 reference

7 January 2021

Etiology of Parkinson's disease: Genetics and environment revisited

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2805%2970097-1

7 January 2021

Neuroprotection in Parkinson disease: mysteries, myths, and misconceptions

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2805%2970097-1

7 January 2021

Mortality and Parkinson disease: A community based study

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2805%2970097-1

7 January 2021

Mitochondria, Oxidative Damage, and Inflammation in Parkinson's Disease

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2805%2970097-1

7 January 2021

Dietary vitamin E and Parkinson's disease: something to chew on

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2805%2970097-1

7 January 2021

Dietary antioxidants and Parkinson disease. The Rotterdam Study.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2805%2970097-1

7 January 2021

Intakes of vitamins E and C, carotenoids, vitamin supplements, and PD risk.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2805%2970097-1

7 January 2021

Dietary antioxidants and other dietary factors in the etiology of Parkinson's disease.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2805%2970097-1

7 January 2021

Dietary factors in Parkinson's disease: the role of food groups and specific foods

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2805%2970097-1

7 January 2021

Odd man out: a graphical approach to meta-analysis.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2805%2970097-1

7 January 2021

Evaluation of old and new tests of heterogeneity in epidemiologic meta-analysis

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2805%2970097-1

7 January 2021

HEpiMA: software for the identification of heterogeneity in meta-analysis.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2805%2970097-1

7 January 2021

Case-control study of idiopathic Parkinson's disease and dietary vitamin E intake.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2805%2970097-1

7 January 2021

Adult nutrient intake as a risk factor for Parkinson's disease

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2805%2970097-1

7 January 2021

Diet and Parkinson's disease. II: A possible role for the past intake of specific nutrients. Results from a self-administered food-frequency questionnaire in a case-control study

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2805%2970097-1

7 January 2021

Risk factors for parkinson's disease: the leisure world cohort study

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2805%2970097-1

7 January 2021

Effects of tocopherol and deprenyl on the progression of disability in early Parkinson's disease

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2805%2970097-1

7 January 2021

Ageing and Parkinson's disease: substantia nigra regional selectivity

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2805%2970097-1

7 January 2021

A "cure" for Parkinson's disease: can neuroprotection be proven with current trial designs?

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2805%2970097-1

7 January 2021

The role of radiotracer imaging in Parkinson disease

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2805%2970097-1

7 January 2021

Levodopa and the progression of Parkinson's disease

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2805%2970097-1

7 January 2021

Ascorbate regulation and its neuroprotective role in the brain

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2805%2970097-1

7 January 2021

Ascorbic acid, redox cycling, lipid peroxidation, and the binding of dopamine receptor antagonists

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2805%2970097-1

7 January 2021

10.1016/S1474-4422(05)70097-1

Identifiers

DOI

1 reference

release_qrisiz7bifbxfnwlnxrpjbenmm

24 July 2017

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/qrisiz7bifbxfnwlnxrpjbenmm

24 November 2022

mapped directly with Wikidata item

1 reference